ACE Inhibitors and Arrhythmias

Overview

Journal Heart

Date 1996 Nov 1

PMID 8977367

Citations 3

Authors

R W CAMPBELL

Affiliations

Soon will be listed here.

Citing Articles

Contemporary approach to understand and manage COVID-19-related arrhythmia.

Nabeh O, Helaly M, Menshawey R, Menshawey E, Nasser M, Diaa El-Deen A Egypt Heart J. 2021; 73(1):76.

PMID: 34459992 PMC: 8403826. DOI: 10.1186/s43044-021-00201-5.

Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study).

Morel E, Manati A, Nony P, Maucort-Boulch D, Bessiere F, Cai X Clin Cardiol. 2018; 41(3):300-306.

PMID: 29574980 PMC: 6490055. DOI: 10.1002/clc.22884.

Prevention of and medical therapy for atrial arrhythmias in heart failure.

Khand A, Cleland J, Deedwania P Heart Fail Rev. 2002; 7(3):267-83.

PMID: 12215732 DOI: 10.1023/a:1020097728178.

References

Reiter M, Synhorst D, Mann D . Electrophysiological effects of acute ventricular dilatation in the isolated rabbit heart. Circ Res. 1988; 62(3):554-62. DOI: 10.1161/01.res.62.3.554. View

Ball S, Hall A, Murray G . ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study. Eur Heart J. 1994; 15 Suppl B:20-5; discussion 26-30. DOI: 10.1093/eurheartj/15.suppl_b.20. View

Dean J, Lab M . Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. Lancet. 1989; 1(8650):1309-12. DOI: 10.1016/s0140-6736(89)92697-4. View

Franz M, Burkhoff D, Yue D, Sagawa K . Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res. 1989; 23(3):213-23. DOI: 10.1093/cvr/23.3.213. View

Clough D, Collis M, Conway J, Hatton R, Keddie J . Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol. 1982; 49(6):1410-4. DOI: 10.1016/0002-9149(82)90352-6. View

Maskin C, Siskind S, Lejemtel T . High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J. 1984; 107(5 Pt 1):896-901. DOI: 10.1016/0002-8703(84)90824-x. View

Chakko C, Gheorghiade M . Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J. 1985; 109(3 Pt 1):497-504. DOI: 10.1016/0002-8703(85)90554-x. View

Packer M . Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985; 72(4):681-5. DOI: 10.1161/01.cir.72.4.681. View

Webster M, Fitzpatrick M, Nicholls M, Ikram H, Wells J . Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985; 56(8):566-9. DOI: 10.1016/0002-9149(85)91186-5. View

10.

Gnecchi M, De Marzio P, Morelli S, Aguglia F . [Suppression of complex ventricular arrhythmias with isosorbide dinitrate in a case of congestive heart failure]. Cardiologia. 1985; 30(5):401-4. View

11.

Bourke J, Cowan J, Tansuphaswadikul S, CAMPBELL R . Antiarrhythmic drug effects on left ventricular performance. Eur Heart J. 1987; 8 Suppl A:105-11. DOI: 10.1093/eurheartj/8.suppl_a.105. View

12.

Cleland J, Dargie H, Ford I . Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987; 58(6):572-82. PMC: 1277308. DOI: 10.1136/hrt.58.6.572. View

13.

Kjekshus J . Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 1990; 65(19):42I-48I. DOI: 10.1016/0002-9149(90)90125-k. View

14.

Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D . Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 1990; 16(7):1711-8. DOI: 10.1016/0735-1097(90)90324-i. View

15.

Linz W, Scholkens B, Kaiser J, Just M, Qi B, Albus U . Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril. Cardiovasc Drugs Ther. 1989; 3(6):873-82. DOI: 10.1007/BF01869575. View

16.

Cohn J, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325(5):303-10. DOI: 10.1056/NEJM199108013250502. View

17.

Stark G, Stark U, Nagl S, Klein W, Pilger E, Tritthart H . Acute effects of the ACE inhibitor lisinopril on cardiac electrophysiological parameters of isolated guinea pig hearts. Clin Cardiol. 1991; 14(7):579-82. DOI: 10.1002/clc.4960140709. View

18.

Fonarow G, Stevenson L, Luu M, Hamilton M, Moriguchi J, TILLISCH J . Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992; 19(4):842-50. DOI: 10.1016/0735-1097(92)90529-v. View

19.

Pfisterer M, Kiowski W, Burckhardt D, Follath F, Burkart F . Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol. 1992; 69(17):1399-402. DOI: 10.1016/0002-9149(92)90889-7. View

20.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View